Search results
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
Digital Journal· 19 hours ago...initiation, enrollment and maintenance of patients, and the completion of clinical trials, the availability and timing of data from ongoing clinical trials, the trial design includes combination therapies that may make it difficult to accurately ascertain the benefits of APVO436, expectations...
Is This a Setback for Moderna?
Motley Fool via Yahoo Finance· 20 hours agoBut there's room for more than one, and Moderna may even excel thanks to a couple of factors. The biotech's candidate wasn't linked to any cases of...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 3 days agoAnd, at a time when its coronavirus vaccine revenue is no longer enough to make the stock as...
Lula’s progress plan for Brazil: A year on
Pharmaceutical Technology via Yahoo Finance· 2 days agoStill he says the handling of the coronavirus in Brazil demonstrated its control was only possible due to technology transfer negotiations among national...
1 No-Brainer Growth Stock to Buy and Hold | The Motley Fool
The Motley Fool· 4 days agoAll of these superlatives (and more) describe Eli Lilly's (LLY -1.50%) performance in recent years...
AstraZeneca withdraws Covid-19 vaccine, citing low demand
CNN Business via AOL· 7 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 day agoPositive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b study evaluating Vaxart
Mers outbreak in Saudi Arabia puts health experts on high alert
The Telegraph via Yahoo News· 5 days agoHealth agencies are racing to determine the origins of a Mers outbreak in Saudi Arabia, after three...
AstraZeneca Is Withdrawing Its Covid Vaccine Worldwide, Citing Low Demand
New York Times· 7 days agoThe shot is no longer being manufactured or supplied, and it is no longer authorized for use in...
Revolutionary “Quartet Nanocage” Vaccine Effective Against Coronaviruses That Haven’t Even Emerged...
SciTechDaily· 2 days agoResearchers have created a new vaccine technology that, in tests with mice, has demonstrated...
